From: Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses
Virus | Exosome diameter (nm) | Exosome viral | Exosome marker | Targets | Functions | References |
---|---|---|---|---|---|---|
HBV | 50–100 | HBx, large S, core, and P proteins | CD9/CD63 | HepAD38, Huh-7 | Enhance virus-associated cellular-transformation | |
HCV | 30–150 | NS3/4 protease, E2, Core, genomic RNA | CD9/CD63/CD81, Hsp70/CD63, CD81/AchE, CD63 | Treg cells | Transmit HCV and enhance persistent infection, Promote HCV productive infection | [44] |
EBV | 40–100 | miR-BHRF1-3, miR-BART15-3p, miR-BART13-3p, LMP-1, LMP-2A, EBERs | HSC70, flotillin-2, CD9, CD81, CD63 | CXCL11, BRUCE, NLRP3, LMP1, ABI2 | Immune-regulatory, Induce cell apoptosis, Decrease anti-viral immune reaction, Mediate the viral latency, Facilitate the growth, migration, and invasion of malignant cells | |
HPV | 50–200 | E6/E7, p16, Survivin | Syntenin | p53, pRb | Promote cellular transformation and cancerization | |
HTLV-1 | 70–100 | Tax, HBZ, gp61, Env | CD45, CD43 | CTLL-2, PBMCs | Cell cycle progression, cell survival, transcription and cell proliferation signaling pathways regulation | |
KSHV | 50–150 | miRK12-3-5p, miR-K12-2-5p, mir-10b-5p, mir-143-3p | CD63 | EGLN1,EGLN2,HSPA9 | Alter host cell energy metabolism | [51] |
MCPyV | 30–150 | CircALTOs, gelsolin, periostin and thrombospondin, LT-ag | CD63,CD81 | MCC, RBPJ, p53 | Transcriptional enhancer, increase proliferation and pathogenicity | [52] |